What is Mycodev Group?
Mycodev Group is a notable player in the advanced materials sector, specializing in the production of high-purity chitosan derived from a sophisticated fungal fermentation process. Unlike traditional animal-derived sources, Mycodev's chitosan is non-animal, offering superior purity and reduced contaminant levels. The company distinguishes itself by providing customizable molecular weight and degree of deacetylation, ensuring that its products precisely meet the stringent requirements of diverse industries, including pharmaceuticals and advanced development sectors. This focus on consistency and traceability positions Mycodev Group as a reliable supplier for clients demanding high-standard biomaterials.
How much funding has Mycodev Group raised?
Mycodev Group has raised a total of $500K across 1 funding round:
Private Equity
$500K
Private Equity (2015): $500K with participation from New Brunswick Innovation Foundation
Key Investors in Mycodev Group
New Brunswick Innovation Foundation
The New Brunswick Innovation Foundation (NBIF) is a key supporter of early-stage startups in New Brunswick, focusing on innovative technologies and venture capital. They aim to enhance profitability and competitiveness of SMEs through strategic investments and programs.
What's next for Mycodev Group?
The substantial enterprise-level funding and recent strategic investment signal a pivotal growth phase for Mycodev Group. This capital infusion is expected to accelerate the company's expansion, potentially enabling enhanced research and development initiatives, scaling of production capabilities, and broader market penetration. The strategic nature of the recent financing suggests a strong alignment with investors who recognize the long-term value and application potential of Mycodev's innovative chitosan solutions, paving the way for significant advancements and market leadership.
See full Mycodev Group company page
